Results 101 to 110 of about 766 (168)

NEOPLASIA DE CÉLULAS DENDRÍTICAS BLÁSTICAS PLASMOCITÓIDES COM ACOMETIMENTO OCULAR: RELATO DE DOIS CASOS

Hematology, Transfusion and Cell Therapy
Introdução: A neoplasia de células dendríticas blásticas plasmocitóides (NCDBP) é rara, seus principais locais de envolvimento são a pele e medula óssea, com frequente envolvimento do sistema nervoso central (SNC).
COC Vieira, Y Gonzaga, C Mattosinho, LVD Valle, SH Nunes, S Garcia, CB Burrowes, RP Souza, TS Gregório, LAO Ananias   +9 more
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm without Cutaneous Manifestation: A Case Report.

, 2021
BACKGROUND As an uncommon malignancy with the highest prevalence in the elderly population, blastic plasmacytoid dendritic cell neoplasm or BPDCN is a hematologic disorder with unknown pathogenesis and devastating outcomes.
Amoozgar, Behzad, Daliparty, Vasudev Malik, Razzeto, Mariano, Garala, Pavan, MD, Rehman, Faseeha, Razzeto, Alejandra   +5 more
core  

P521: TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY

HemaSphere, 2022
N. Pemmaraju, B. Cuglievan, J. Lasky, A. Kheradpour, N. Hijiya, A. S. Stein, S. Meshinchi, C. Mullen, E. Angelucci, L. Vinti, T. I. Mughal, A. Pawlowska   +11 more
doaj   +1 more source

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) international registry: Assessment of the allo-HCT outcomes

Background: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an underdiagnosed rare disease with poor outcomes and limited treatment options.
Attardi, Enrico, Voskanyan, Astghik, Peng, Ching-Tien, Ohannessian, Robin, Konopleva, Marina, Tamamyan, Gevorg, Michael, Michalis, Martelli, Maria Paola, Mehra, Shefali, Bedirian, Karen, Martirosyan, Nare, Komrokji, Rami, Abramashvili, Mariam, Ivanyan, Arusyak, Kutluk, Tezer, Tuğcu, Deniz, Papyan, Ruzanna, Alhuraiji, Ahmad, Tekkesin, Funda, Taylor, Justin, Al-Jadiry, Mazin Faisal, Ghali, Hasanein, Voso, Maria Teresa, Su, Min-Yu, Badikyan, Maria, Stancioaica, Maria Camelia, Grigoryan, Hayk, Hovsepyan, Shushan, El-Ashwah, Shaimaa, Harutyunyan, Lusine, Owen, Carolyn, Ghahramanyan, Nerses, Bakhshi, Sameer, Maghaqyan, Hasmik, Kebudi, Rejin, Pemmaraju, Naveen, Kotoucek, Pavel, Bardakhchyan, Samvel, Elashwah, Salma, Kazandjian, Dickran, Coriu, Daniel, Alencar, Alvaro, Totogashvili, Nino   +42 more
core   +1 more source

Développement d’un CAR-NK et évaluation de thérapies ciblées anti-CD123 pour la prise en charge d’hémopathies impliquant les cellules dendritiques plasmocytoïdes

Les leucémies à des cellules dendritiques plasmocytoïdes (LpDC) ainsi que les leucémies aigües myéloïdes avec excès de cellules dendritiques plasmocytoïdes (LAM-pDC), sont des entités récemment décrites qui ont en commun la prolifération excessive de ...
Boichut, Morgane
core   +1 more source

P531: AN OBSERVATIONAL, MULTICENTER, RETROSPECTIVE ANALYSIS OF PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH TAGRAXOFUSP IN THE EUROPEAN EXPANDED ACCESS PROGRAM

HemaSphere, 2022
M. Herling, E. Deconinck, M. Anant, D. Manteigas, M. Riggi, E. Angelucci   +5 more
doaj   +1 more source

P529: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST-IN-CLASS CD123-TARGETED THERAPY TAGRAXOFUSP

HemaSphere, 2022
U. Platzbecker, E. Angelucci, P. Montesinos, R. M. Lemoli, A. Spyridonidis, J. Casariego, T. I. Mughal, M. Mohty   +7 more
doaj   +1 more source

P530: TAGRAXOFUSP IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM WITH/WITHOUT CENTRAL NERVOUS SYSTEM INVOLVEMENT AND INTRATHECAL CHEMOTHERAPY AS PRIMARY TREATMENT OR PROPHYLAXIS: AN ITALIAN EXPERIENCE.

HemaSphere, 2022
G. Rivoli, G. Beltrami, A. Raiola, A. Dominietto, M. Riggi, E. Angelucci   +5 more
doaj   +1 more source

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II. [PDF]

Leukemia
Beird HC, Kannan S, Liu J, Chen J, Olguin A, Desai P, Cai T, Han L, Cotton JL, Singh S, Gupta SK, Little L, Estecio MR, Song X, Abbas HA, Zhang J, Gumbs C, Brooks C, Kantarjian H, Andreeff M, Konopleva M, Futreal PA, Pemmaraju N.   +22 more
europepmc   +1 more source

PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

HemaSphere, 2023
Uwe Platzbecker, Emanuele Angelucci, Pau Montesinos, Roberto M. Lemoni, Alexandros Spyridonidis, Marcello Riggi, Michael Zuurman, Mohamad Mohty   +7 more
doaj   +1 more source